Florida Grand Jury Exposes COVID Vaccine Approval Failures
Submitted by MAGA
Posted 9 hours ago
**Bombshell Report Exposes Flaws in COVID Vaccine Approval Process**
In a striking revelation, a Florida grand jury has unveiled a comprehensive report detailing significant issues in the approval and promotion of COVID-19 vaccines, specifically those manufactured by Pfizer and Moderna.
Commissioned by Governor Ron DeSantis and authorized by the Florida Supreme Court, this investigative report has reignited discussions around the accountability of pharmaceutical giants and federal health agencies. The jury's findings challenge the narratives pushed by various government officials and health authorities throughout the pandemic.
While the grand jury ultimately chose not to pursue criminal charges, its report documented a plethora of unethical practices and alarming statements made by both vaccine manufacturers and regulatory bodies. Most notably, the jury criticized the Food and Drug Administration (FDA) for granting Emergency Use Authorization (EUA) too broadly, suggesting it should have been restricted to the most vulnerable populations, such as the elderly and those with pre-existing conditions.
The report emphasizes that the FDA's actions lacked rigorous testing protocols, particularly regarding the impact of vaccines on pregnant women. The jurors expressed their belief that the health apparatus failed to adequately protect expectant mothers, who were treated as "human guinea pigs" in clinical trials without thorough risk assessments.
A concerning aspect highlighted by the grand jury was the apparent negligence by Pfizer and Moderna in completing mandatory post-market studies to evaluate safety and efficacy. Both companies have reportedly missed crucial deadlines, raising questions about how diligently they are monitoring the side effects of their vaccines, which have already cost American taxpayers billions of dollars.
Moreover, the report points to significant gaps in public disclosure about potential risks associated with the vaccines, including cases of myocarditis and Guillain-Barré syndrome linked to other vaccines recently approved by the FDA. The jury critiqued the "paternalistic attitude" of health agencies, which seem to prioritize their narratives over transparency, undermining public trust in vaccinations.
The finding that most Americans have likely contracted and recovered from COVID-19 calls into question the need for ongoing vaccine campaigns, particularly as variants continue to emerge. As national discourse begins to reflect these findings, it remains imperative for lawmakers and public health leaders to ensure that data and safety reports are delivered transparently.
While the grand jury's recommendations may not result in immediate legal action, they urge federal and state officials to reconsider current vaccine approval processes, possibly initiating necessary reforms to prevent similar issues in the future.
As the narrative around vaccines continues to evolve, America must grapple with the implications of this groundbreaking report. The urgency for accountability within both the pharmaceutical industry and regulatory agencies has never been clearer.
Sources:
thefederalist.com
sharylattkisson.com
globalresearch.ca
In a striking revelation, a Florida grand jury has unveiled a comprehensive report detailing significant issues in the approval and promotion of COVID-19 vaccines, specifically those manufactured by Pfizer and Moderna.
Commissioned by Governor Ron DeSantis and authorized by the Florida Supreme Court, this investigative report has reignited discussions around the accountability of pharmaceutical giants and federal health agencies. The jury's findings challenge the narratives pushed by various government officials and health authorities throughout the pandemic.
While the grand jury ultimately chose not to pursue criminal charges, its report documented a plethora of unethical practices and alarming statements made by both vaccine manufacturers and regulatory bodies. Most notably, the jury criticized the Food and Drug Administration (FDA) for granting Emergency Use Authorization (EUA) too broadly, suggesting it should have been restricted to the most vulnerable populations, such as the elderly and those with pre-existing conditions.
The report emphasizes that the FDA's actions lacked rigorous testing protocols, particularly regarding the impact of vaccines on pregnant women. The jurors expressed their belief that the health apparatus failed to adequately protect expectant mothers, who were treated as "human guinea pigs" in clinical trials without thorough risk assessments.
A concerning aspect highlighted by the grand jury was the apparent negligence by Pfizer and Moderna in completing mandatory post-market studies to evaluate safety and efficacy. Both companies have reportedly missed crucial deadlines, raising questions about how diligently they are monitoring the side effects of their vaccines, which have already cost American taxpayers billions of dollars.
Moreover, the report points to significant gaps in public disclosure about potential risks associated with the vaccines, including cases of myocarditis and Guillain-Barré syndrome linked to other vaccines recently approved by the FDA. The jury critiqued the "paternalistic attitude" of health agencies, which seem to prioritize their narratives over transparency, undermining public trust in vaccinations.
The finding that most Americans have likely contracted and recovered from COVID-19 calls into question the need for ongoing vaccine campaigns, particularly as variants continue to emerge. As national discourse begins to reflect these findings, it remains imperative for lawmakers and public health leaders to ensure that data and safety reports are delivered transparently.
While the grand jury's recommendations may not result in immediate legal action, they urge federal and state officials to reconsider current vaccine approval processes, possibly initiating necessary reforms to prevent similar issues in the future.
As the narrative around vaccines continues to evolve, America must grapple with the implications of this groundbreaking report. The urgency for accountability within both the pharmaceutical industry and regulatory agencies has never been clearer.
Sources:
thefederalist.com
sharylattkisson.com
globalresearch.ca
Latest News